Comparison of bone marrow and peripheral blood aberrant plasma cell assessment by NGF in patients with MM

Affiliations

• ¹ Department of Hematology, Oncology, and Rheumatology, Heidelberg University Hospital, Heidelberg, Germany.
• ² Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany.
• ³ Department of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Düsseldorf, Germany.
• ⁴ Department of Internal Medicine II, University Hospital Tübingen, Tübingen, Germany.
• ⁵ Department for Hematology and Stem Cell Transplantation, University Hospital Essen, Essen, Germany.
• ⁶ Department of Hematology and Oncology, Ruhr-University Bochum, Bochum, Germany.
• ⁷ Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Goethe University, Frankfurt am Main, Germany.
• ⁸ Department of Internal Medicine III, Clinic Chemnitz, Chemnitz, Germany.
• ⁹ Department for Hematology, Oncology and Immunology, University Hospital Gießen and Marburg, Marburg, Germany.
• ¹⁰ Department of Oncology, Hematology and Bone Marrow Transplant, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
• ¹¹ Clinic for Oncology and Hematology, Hospital Barmherzige Brueder Regensburg, Regensburg, Germany.
• ¹² National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.
• ¹³ Medizinisches Versorgungszentrum am Kreiskrankenhaus Bergstraße gGmbH, Heppenheim, Germany.